B超引导下冷循环微波刀治疗原发性肝癌的临床价值.docVIP

精品论文 参考文献 B超引导下冷循环微波刀治疗原发性肝癌的临床价值 田慧 徐庆杰 和振坤 （河南大学淮河医院 河南开封 475000) 　　【中图分类号】R735.7 【文献标识码】A【文章编号】1672-5085（2013）30-0054-03 　　【摘要】 目的 观察 B超引导下冷循环微波刀治疗原发性肝癌的临床效果。方法 2006年12月至2012年1月于我科诊治因各种原因无法进行手术的PLC患者，共82例，行B超引导下冷循环微波刀，观察术中、术后并发症发生情况，动态监测术后AFP及肝功能变化、生活质量及近期生存率。结果 本组患者在术中、术后均未出现严重并发症，患者生存质量、临床症状、AFP等均明显改善，术后1、2、3年生存率分别为81.3％、62.7％和39.8％，1年生存率较外科手术切除相近，2、3年生存率较其有所升高。结论 B超引导下冷循环微波刀作为治疗PLC的一门新技术，能切实改善患者的生存质量、临床症状，提高???后生存率。 　　【关键词】 B超引导 冷循环微波刀 原发性肝癌 　　 　　Clinical value of B ultrasound-guided psychro-circulation percutaneous microwave coagulation therapy in treating Primary liver cancer(PLC). 　　Tian Hui Xu Qing-jie He Zhen-kun﹡ 　　﹡Huaihe Hospital of Henan University in Kaifeng, Henan 475000 　　【Abstract】 ObjectiveTo explore the clinical value of B ultrasound-guided psychro-circulation percutaneous microwave coagulation therapy in treating Primary liver cancer. Methods 82 cases with PLC who could not undergo surgery for various reasons were selected to receive B ultrasound-guided psychro-circulation percutaneous microwave coagulation therapy from Dec.2006 to Jan.2012 in our hospital. The pre-and postoperative clinical symptoms、alpha fetoprotein(AFP) levels、liver function and quality of life were detected.The postoperative 1.2 and 3 Y survival rate of those patients was followed up and recorded.Results No severe complications occurred in this series. patients quality of life、clinical symptoms and AFP were obviously improved.The postoperative 1，2 and 3 Y survival rate was 81.3％、62.7％ and 39.8％. Conclusions psychro-circulation percutaneous microwave coagulation therapy is an efective method for treating PLC， and it is especially suitable for inoperable patients，because of its few complications and convenient performance. 　　【Key words】B ultrasound-guided psychro-circulation percutaneous microwave coagulation therapy PLC 　　原发性肝癌(Primary liver cancer，PLC)是我国常见的恶性肿瘤之一，目前手术切除仍是肝癌治疗的首选手段，但因其起病隐匿，绝大多数患者确诊时已属于中晚期, 手术切除机会只有10％-15％。临床实践中更多的患者需要手术切除以外的治疗方法，其中冷循环微波